logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Dixon Technologies: Key broker targets and levels 2026

DIXON

Dixon Technologies (India) Ltd

DIXON

Ask AI

Ask AI

What moved Dixon Technologies on Wednesday

Dixon Technologies jumped nearly 10% in Wednesday’s trade after the company posted its Q4 results. The move was followed by a pullback in the next session, with the stock down 2.3% at ₹10,860. In another snapshot of the same trading week, the current market price was cited at ₹11,114. The mixed price action kept Dixon in focus, with brokerages revisiting their assumptions and traders tracking key technical levels.

Nomura stays positive but trims target

Analysts at Nomura maintained a ‘Buy’ rating on Dixon Technologies after the earnings update. But Nomura lowered its target price to ₹13,813 from ₹14,678 projected earlier. The brokerage cited concerns over a delay in Vivo approval and a subdued demand outlook as key reasons for the cut. The change highlights how near-term execution milestones and demand visibility can influence valuation even when the broader recommendation is unchanged.

Another brokerage reiterates ‘Add’ with ₹11,200 target

A separate brokerage note in the provided text reiterated an ‘Add’ rating with a target price of ₹11,200. This target sits close to the cited current market price of ₹11,114, implying limited near-term upside based on that view. While the source name is not specified in the excerpt, the call adds to the wider range of targets visible for the stock across reports.

Technical view: five-month consolidation and a reversal setup

Technical analyst Mishra said Dixon Technologies has been in a consolidation phase for the last five months and is now showing signs of a potential reversal. According to this view, a breakout above the ₹11,500 to ₹11,700 zone is a key trigger. If the stock crosses that barrier, it could potentially rally past the ₹13,000 mark. Mishra also flagged strong support around ₹10,000, describing it as an important level for risk management.

Suggested trading strategy and risk levels

As a trading strategy, Mishra suggested buying the stock on a breakout above ₹11,700. Alternatively, he suggested buying on dips closer to ₹10,000. The framework anchors entries around clearly defined levels, with resistance at ₹11,500 to ₹11,700 and support near ₹10,000. These levels matter because they align with the consolidation range described for the last five months.

CLSA downgrade to ‘hold’ and sharp target cut

One report in the provided text said global brokerage CLSA downgraded Dixon Technologies to ‘hold’ from ‘outperform’ and cut its target price by 23% to ₹12,100 from ₹15,800. The report also noted the stock fell nearly 3% after the downgrade. A separate snippet summarised CLSA’s rationale as cutting estimates due to low mobile volume and said the near-term growth trajectory looked clouded.

CLSA also cited in later notes with different targets

The excerpts also include other CLSA-related updates that point to changing assumptions over time. One update said CLSA reduced its target by around 16% to ₹15,880 from ₹18,800, while retaining an ‘outperform’ call due to visibility of a medium-term recovery; at 0951 IST, the stock was up 0.2% at ₹11,880 on the NSE. Another excerpt said CLSA maintained an ‘Outperform’ rating with a target price of ₹18,800 per share, implying nearly 45% upside from a previous close of ₹12,988, with Dixon shares closing at ₹13,365 on a Friday mentioned in the text. There is also an Investing.com line stating CLSA lowered its price target to ₹15,880 from ₹18,800 while maintaining an Outperform rating.

Street positioning: buy-heavy, but targets vary by dataset

The text references multiple broker consensus snapshots sourced to Informist. In one compilation of 13 brokerage reports, 12 carried a ‘buy’ recommendation with an average target price of ₹13,952, while one brokerage had a ‘sell’ recommendation. In another compilation of 16 research reports, 12 had ‘buy’ or equivalent with an average target price of ₹17,724; of the remaining four, two had ‘hold’ and the rest had ‘reduce’. These variations show that the headline consensus can shift depending on the time window and the set of reports being counted.

Key numbers table: ratings, targets and levels mentioned

ItemDetail (as cited in the text)
Wednesday move after Q4 resultsStock surged nearly 10%
Next-session moveDown 2.3% at ₹10,860
Current market price (separately cited)₹11,114
Nomura rating and target‘Buy’; target cut to ₹13,813 from ₹14,678
Additional brokerage call‘Add’; target ₹11,200
Technical resistance zone₹11,500 to ₹11,700
Technical supportAround ₹10,000
CLSA downgrade note‘Hold’ from ‘Outperform’; target ₹12,100 from ₹15,800
CLSA separate noteTarget ₹15,880 from ₹18,800; ‘Outperform’ retained
CLSA Dec 12 related mention‘Outperform’; target ₹18,800; stock closed ₹13,365 (previous close ₹12,988)

Why the story matters for investors

The sharp swings between post-results optimism and subsequent downgrades underline the sensitivity of Dixon’s valuation to mobile volumes, approvals tied to large customers, and near-term demand expectations. The range of targets in the excerpts, from ₹11,200 to above ₹18,000, shows that forecasts for earnings and margins are not tightly clustered. For shorter-term participants, the widely cited ₹10,000 support and ₹11,700 breakout level create reference points for setting risk and position sizing. For longer-term investors, the broker commentaries reflect a debate on near-term weakness versus the visibility of a medium-term recovery cited in some reports.

What to watch next

Investors will likely track follow-through after the Q4-driven price move, any updates linked to the Vivo approval timeline referenced by Nomura, and whether the stock can clear the ₹11,500 to ₹11,700 resistance band highlighted by technical analysts. Broker notes may continue to evolve as demand indicators and order visibility change, which has already been reflected in multiple target revisions cited in the excerpts.

Frequently Asked Questions

The stock jumped nearly 10% in Wednesday’s trade after the company posted its Q4 results, as cited in the provided text.
Nomura maintained a ‘Buy’ rating but cut its target price to ₹13,813 from ₹14,678, citing Vivo approval delay concerns and a subdued demand outlook.
The excerpt cites resistance around ₹11,500 to ₹11,700, potential upside beyond ₹13,000 if that zone is crossed, and support around ₹10,000.
One report says CLSA downgraded the stock to ‘hold’ from ‘outperform’ and cut its target 23% to ₹12,100 from ₹15,800; other excerpts cite different target revisions over time.
As per Informist snapshots in the text, one dataset of 13 reports had 12 ‘buy’ and one ‘sell’ with an average target of ₹13,952; another dataset of 16 reports had an average target of ₹17,724 with a mix of ‘buy’, ‘hold’, and ‘reduce’ calls.

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker